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Abstract
The mammalian gut ecosystem has significant influence on host physiology1–4, but the
mechanisms that sustain this complex environment in the face of different stresses remain obscure.
Perturbations to this ecosystem, such as through antibiotic treatment or diet, are currently
interpreted at the level of bacterial phylogeny5–7. Less is known about the contributions of the
abundant population of phage to this ecological network. Here, we explore the phageome as a
potential genetic reservoir for bacterial adaptation by sequencing murine fecal phage populations
following antibiotic perturbation. We show that antibiotic treatment leads to the enrichment of
phage-encoded genes that confer resistance via disparate mechanisms to the administered drug as
well as genes that confer resistance to antibiotics unrelated to the administered drug, and we
demonstrate experimentally that phage from treated mice afford aerobically cultured naïve
microbiota increased resistance. Systems-wide analyses uncover post-treatment phage-encoded
processes related to host colonization and growth adaptation, indicating that the phageome broadly
enriches for functionally beneficial genes under stress-related conditions. We also show that
antibiotic treatment expands the interactions between phage and bacterial species, leading to a
more highly connected phage-bacterial network for gene exchange. Our work implicates the
phageome in the emergence of multidrug resistance and indicates that the adaptive capacity of the
phageome may represent a community-based mechanism for protecting the gut microflora,
preserving its functional robustness during antibiotic stress.
Antibiotic treatment, an important and often necessary therapeutic intervention, can
negatively impact the mammalian gut environment, potentially giving rise to immune2 and
metabolic deficiencies8. Studies on the disruption of intestinal homeostasis have focused on
the resulting alterations in microbial composition6,7. However, investigation of the gut
ecosystem has evinced a myriad of resident phage9, and it remains unclear how perturbation
of the gut environment affects these symbionts. Phage can contribute genes that are
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advantageous to their microbial hosts10,11, in turn promoting their own survival and
propagation12. This gene flow suggests that phage may play an important role in the
adaptation of the microbiome to stressful environments. In this work, we used a comparative
metagenomic approach to explore the effects of antibiotic perturbation on functions encoded
in the phageome as well as to examine how antibiotic treatment alters the phage-bacterial
ecological network.
We treated groups of young adult mice (n = 5) orally with physiologically relevant
concentrations of ciprofloxacin (a quinolone that inhibits DNA synthesis) or ampicillin (a β-
lactam that inhibits cell-wall synthesis), each with a respective control. We obtained
collective fecal samples from each group after eight weeks of treatment and purified phage
as previously described9,13. DNA was extracted from phage and whole-genome amplified
before performing shotgun 454 GS FLX+ pyrosequencing. We obtained a total of 440,792
quality reads, with a median read length of 477 nt (210 Mb total; Fig. S1). Evaluation of
contamination by quantification of bacterial 16S ribosomal RNA genes indicated that
contaminating bacterial sequences represented less than 0.1% of our data, which was
subsequently accounted for in all statistical analyses (see Supplementary Discussion and
Fig. S2).
Phage DNA sequences were compared to the non-redundant NCBI protein and
environmental protein databases (BLASTX; E-value < 10−5). Approximately 70% of reads
were not assigned to previously sequenced genes (Fig. S3), suggesting that the mouse
phageome, like many other viral communities14,15, harbors uncharacterized genetic material.
We used the most significant BLAST alignment of a sequence, when available, to determine
its phylogenetic origin. Most of the identifiable phage in our mouse phageomes (Fig. S4a)
were from the Caudovirales order, comprising the tailed phage families Siphoviridae,
Podoviridae, and Myoviridae, many of which are known to have a temperate life cycle.
Since phage genomes incorporate bacterial genes, we also identified bacterial taxa; we found
that 97% of phage-encoded bacterial genes were attributed to the four phyla known to
dominate the gut (the Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria; Fig.
S4b), consistent with the known hosts of the phage we detected.
We hypothesized that antibiotic treatment leads to increases in phage-encoded genes for
drug resistance. To investigate this, we compared DNA sequences in the phageome to an
assembled database of antibiotic resistance proteins (BLASTX; E-value < 10−3, see
Methods). We found that reads annotated as antibiotic resistance genes were highly enriched
in phage metagenomes from mice treated with ciprofloxacin or ampicillin compared to those
from control mice (Z = 7.3 and Z = 7.0, respectively; Fig. S5; read annotations enumerated
in Table S1). We catalogued the resistance reservoir by annotating phage-encoded genes
based on the drug class to which they confer resistance (Fig. 1a). Our analysis revealed that
resistance to the administered drug class was enriched in phage metagenomes from
antibiotic-treated mice, such that resistance to DNA synthesis inhibitors was enriched in
ciprofloxacin treatment (Z = 2.6), and resistance to cell-wall synthesis inhibitors was
enriched in ampicillin treatment (Z = 5.0). Additionally, upon drug treatment, new resistance
genes were found in the phageome. For example, phage from ciprofloxacin-treated mice
carried genes encoding numerous quinolone efflux pumps (e.g., norM, mexD, mexF), and
phage from ampicillin-treated mice carried genes encoding sensor and response regulators of
cell-wall synthesis inhibitors (e.g., vanRS).
Of note, resistance to other, orthogonal drug classes was also overrepresented in the
antibiotic-perturbed phageomes. Both treatments led to significant enrichment of resistance
to antibiotics that target protein synthesis, and ciprofloxacin treatment also led to significant
enrichment of resistance to cell-wall synthesis inhibitors (Fig. 1a). This cross-resistance was
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mediated by drug-specific inactivators (e.g., chloramphenicol acetyltransferases), as well as
multidrug resistance exporters (e.g., mdtK; Table S1). Together, these findings implicate the
phage metagenome as a potential source of multidrug resistance during antibiotic treatment
of the host.
We aimed to understand the specific mechanisms represented in phage-encoded genes
conferring resistance to the most significantly enriched classes of antibiotics: inhibitors of
cell-wall synthesis, DNA synthesis, and protein synthesis. We categorized resistance genes
according to primary resistance mechanisms, which include modification or protection of
the drug target (target modification), enzymatic inactivation of the drug (drug inactivation),
and transport of the drug out of the cell (efflux)16. Using this framework to classify phage-
encoded resistance genes, our analysis revealed that antibiotic treatment led to disparate
resistance mechanism profiles for each drug class (Fig. 1b). Analysis of resistance to cell-
wall synthesis inhibitors showed that all types of resistance mechanisms were significantly
enriched under both ciprofloxacin treatment and ampicillin treatment. In contrast, resistance
to DNA synthesis and protein synthesis inhibitors occurred predominantly by efflux.
Resistance to protein synthesis inhibitors occurred by target modification and drug
inactivation mechanisms at low levels, and, in accord with its rarity, resistance to DNA
synthesis inhibitors via drug inactivation was not detected. These data likely reflect
resistance mechanisms that are both environmentally available in the gut ecosystem and
impose sustainable in vivo fitness costs. As continued treatment with an antibiotic invariably
leads to its own resistance, mechanisms that enable cross-resistance encoded by the
phageome may be an important consideration when selecting subsequent therapeutics.
We next sought to demonstrate that phage from antibiotic-treated mice confer increased
drug resistance to the host-associated bacterial community. We assessed the frequency of
resistant isolates from aerobically cultured naïve microbiota that were infected ex vivo with
phage from antibiotic-treated or control (untreated) mice. Our results show that this fraction
of microbiota infected with phage from mice administered ciprofloxacin or ampicillin
yielded two to three times more colonies resistant to the respective drug than the aerobically
cultured fraction of microbiota infected with phage from control mice (Fig. 1c). These data
indicate that phage from antibiotic-treated mice can contribute relevant functional
advantages to their microbial hosts.
We next took a systems-level approach and classified other phage-encoded genes into
functional pathways described by the Kyoto Encyclopedia of Genes and Genomes (KEGG)
database. We depicted enriched functional changes in phage metagenomes following
antibiotic treatment as a network diagram (Fig. 2; abundances shown in Fig. S6). Among the
most significantly enriched pathways were functional properties related to the mode of
action of the administered drug (Table S2). Phageomes from ampicillin-treated mice were
enriched for the amino sugar and nucleotide metabolism pathway (part of the broader
carbohydrate metabolism process; Z = 5.6) indicating overrepresentation of genes related to
synthesis of cell wall constituents, and increases in these components have been shown to be
requisite for drug resistance in clinical isolates17. Additionally, we found that phageomes
from ciprofloxacin-treated mice were enriched for replication- and repair-related pathways,
including base excision repair (Z = 6.1), nucleotide excision repair (Z = 7.4), and
homologous recombination (Z = 11.2). Included in these pathways are members of the GO
system for the repair of DNA oxidative lesions, which has been demonstrated to reduce
cytotoxicity due to a range of antibiotic classes18. Also represented are members of the
DNA damage-inducible SOS system, known to provide protection against antibiotic-
mediated cell death and induce the development of resistance-conferring mutations19.
Furthermore, hyper-recombination has been shown to promote multidrug resistance
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phenotypes20. These results show that under drug treatment, the phageome encodes diverse
mechanisms for modulating antibiotic susceptibility.
We also observed that phage metagenomes from antibiotic-treated mice were enriched for
microbial functions that contribute to host metabolism (Fig. 2 and Table S2). Phageomes
from ciprofloxacin-treated mice were uniquely enriched for pathways relevant to the
metabolism of cofactors and vitamins, including thiamine, an essential nutrient provided by
the microbiome. Microbiota ferment polysaccharides indigestible by the host alone;
metabolism of these sugars enables bacterial survival in and colonization of the gut
environment21 and, as a beneficial consequence, provides energy to the host4. We found that
polysaccharide degradation genes, specifically related to metabolism of starch, cellulose,
lactose, and fructans (plant-derived fructose polymers), were enriched with antibiotic
treatment (Fig. 3a). Genes coding for carbohydrate active enzymes (CAZymes), which
enable bacteria to ferment a variety of dietary and host-sourced glycans, were also enriched
under antibiotic treatment and represented by a range of glycoside hydrolase and
glycosyltransferase families (Fig. S7 and Table S3). Because many gut microbes express
only a specific array of carbohydrate-degrading enzymes22, bacteria which acquire these
genes from the phage reservoir may gain additional foraging capacity and, consequently, a
selective growth advantage. These results suggest that the phageome may be an adaptive
repository for functions important for the host-commensal relationship that may otherwise
be depleted by antibiotic perturbation. (See Supplementary Information for additional
discussion.)
We next aimed to elucidate the phylogenetic basis of these phage-encoded bacterial
functions. In Fig. 3b, we illustrate the taxonomic composition of all sequences of bacterial
origin and sequences annotated with enriched functions following drug perturbation.
Examining bacterial phylotypes that contribute antibiotic resistance genes to the phage
metagenome, we found a comparatively high representation of the Clostridia class and a low
representation of the Bacilli class. Notably, a large fraction of CAZyme-annotated sequences
originated from the Bacteroidetes class, which comprises members found to have diverse
capabilities for carbohydrate metabolism22. Investigation of thiamine metabolism reveals
that the Bacilli and Verrucomicrobia classes constitute a large proportion of these
annotations. Since the phageome reflects emergent properties of its environment15,
phylogenetic analyses of phage-encoded elements may more broadly enable the
identification of bacteria actively contributing to specific functions in the gut environment.
Our results show that the phageome harbors a diversity of potentially beneficial functional
elements in the face of antibiotic perturbation. However, the extent to which this genetic
reservoir is accessible to members of the microbiota remains unclear23. To investigate this,
we sought to elucidate the phage-bacterial ecological network and how it changes under
antibiotic treatment. We approximated the network of phage-microbe interactions with
relationships identified through the reconstruction and analysis of individual viral genomes.
De novo assembly was accomplished using stringent parameters (see Methods).
Reconstructed viral genomes are composed of a mosaic of bacterial genes, and we utilized
the phylogenetic origins of these sequences to determine putative phage-bacterial
associations (Fig. 4). Our resulting network recapitulated known interactions, including the
lysogenic relationships of foodborne pathogens, such as bacteriophage phi3626 infection of
C. perfringens24 and Siphoviridae Listeria phage A500 infection of L. monocytogenes25.
Importantly, antibiotic treatment leads to widespread restructuring of the phage-bacterial
ecological network (Fig. 4). These data show that new links between phage and bacteria are
formed with drug treatment, giving rise to significantly greater network connectivity (Fig.
S8). This increased connectivity is reflective of phage broadly, as more bacterial species are
associated with a given phage (Fig. S9). These results suggest that antibiotic treatment
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increases the frequency of phage integration and stimulates broad host range, which
promotes a functional reservoir that is both genetically diverse and highly accessible by gut
bacteria.
While the phageome is a highly connected network for gene exchange, the functional
consequence of acquiring genetic material from this reservoir depends on the molecular
context of the host bacterium. Acquisition of a single gene may enhance an existing function
by gene dosage or enable a novel phenotype. As some proteins rely on additional machinery,
subsequent horizontal gene transfer events may be required to produce a phenotype.
Moreover, redundantly acquired genes may gain new functionality through paralogous
evolution.
Here we demonstrate that antibiotic treatment enriches the phage metagenome for stress-
specific and niche-specific functions, while mediating changes in the topology of the phage-
bacterial ecological network to potentiate accessibility of these genetic elements. Functional
resilience of the microbiome following environmental perturbation has been empirically
documented and has engendered interest in the restorative forces that return the commensal
flora to its pre-perturbed state6,7,26. Our results implicate phage encapsulation of adaptive
signatures as a community-based mechanism for functional robustness in the gut
environment during stress. Of note, antibiotic treatment can also prime the gut environment
for pathogen invasion2, and our findings pose potential implications for the emergence of
drug resistance and evasion strategies in pathogenic populations. Cohabitation of phage and
bacteria in the gut ecosystem is likely governed by complex and dynamic interactions,
particularly during stress perturbation. Additional work is needed to discern the selective
pressures imposed on each member of this community and the resulting mechanisms that
influence the encoding and progressive enrichment of functionally beneficial genes in the
phageome. Phage-mediated gene flow may be an important phenotypic buffer for bacterial
communities, and further investigation of the adaptive reservoir of the phageome and the
dynamic nature of the phage-bacterial ecological network may prove critical to
understanding the influence of the gut ecosystem on host physiology.
Methods
Mouse study
All experiments involving animals were pre-reviewed and approved by the Boston
Children’s Hospital Institutional Animal Care and Use Committee (IACUC). Groups of
separately housed 6-week-old female FVB/NJ mice (n = 5; Jackson Laboratory) were
treated with ampicillin (142.5 mg/L) or ciprofloxacin (62.5 mg/L) in their drinking water.
The corresponding dosage was 28.5 mg/kg/day ampicillin and 12.5 mg/kg/day
ciprofloxacin, based on the average mouse weight of 20 g and an approximate intake of 4 ml
per day. Control mouse groups were supplied with standard drinking water (ampicillin) or
alkaline water (ciprofloxacin). Treatments were refreshed twice per week. Mice were housed
in sterile conditions and received autoclaved chow during the course of this study. We
harvested fresh collective fecal samples from each group to obtain ample material (3–4 g)
for purification. Samples were stored at −80 °C prior to use.
Viral purification and preparation of genomic DNA
Viral purification from fecal samples of mice after eight weeks was performed as previously
described9,13. An aliquot of the viral preparation (1.5 g ml−1 layer from ultracentrifugation)
was stained with SYBR gold and visualized with epifluorescence microscopy to verify the
absence of bacterial contamination. Viral particles were concentrated and desalted using an
Ultra-4 Centrifugal Filter Unit (Ultracel-30K MWCO; Millipore) to a volume of ~200 μl.
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Concentrated viral samples were treated with DNase (0.2 mg/ml) and samples were passed
through a 0.22 μM filter to ensure no procedural contamination was introduced. Genomic
DNA was extracted using the QiaAMP DNA mini kit (Qiagen) using the protocol for viral
DNA detailed in the manual. Genomic DNA was amplified using the Illustra Genomiphi v2
kit (GE) according to manufacturer’s instructions. For each sample, we pooled amplified
DNA from three separate reactions to minimize bias.
Next-generation sequencing
Viral DNA was submitted to the Tufts Genomic Core for library preparation and shotgun
sequencing. Equimolar concentrations of multiplexed (Rapid Library MID) samples were
pooled on a single plate and pyrosequenced using the 454 GS FLX+ platform. Resulting
sequences were filtered by removing duplicates using the tool available at http://
microbiomes.msu.edu/replicates/28 with the following parameters: sequence identity cutoff
= 97%; length difference requirement = 0; number of beginning base pairs to check = 20.
Antibiotic resistance annotations
To facilitate annotation of antibiotic resistance genes, we assembled a database consisting of
the Antibiotic Resistance Genes Database27 and UniProt proteins annotated with the GO
term “antibiotic breakdown” (GO: 0017001) to achieve a total of 12,687 protein sequences.
The functional annotations of the proteins in this database are supported by either
experimental validation or high-quality computational prediction. Viral DNA sequences
were compared to this database using BLASTX, and sequences with an E-value < 10−3 were
deemed significant. This cutoff was selected to maintain a consistent stringency, by
accounting for database size, with functional annotation to the NCBI databases.
Functional annotations
Phage DNA sequences were compared to the non-redundant NCBI protein (nr) and
environmental protein (env_nr) databases (BLASTX; E-value < 10−5). Sequences were
annotated with KEGG29 (v61.0) using custom Perl scripts interfaced with the KEGG API.
The most significant BLAST hit that resulted in a KEGG annotation was used, and we
included all annotations in the event that a hit had multiple annotations. KEGG ortholog
annotations were compared to glycoside hydrolases and glycosyltransferases found on
www.cazy.org30 to identify CAZyme-encoding genes.
Statistical testing
To compare the functional annotations of two metagenomic datasets, A and B, we generated
a distribution for each A and B reflecting the number of annotations from 10,000 trials of
random sampling with replacement, sampled at the number of reads in the comparison
dataset. To account for the effects of contaminating bacterial DNA in our comparative
metagenomic analyses, we assumed that contamination would be uniformly distributed and
therefore we randomly discarded bacterial reads in each sampling trial according to the
amount of contamination detected by quantitative PCR. We compared the number of
annotations identified in a given sample to the comparison distribution and determined a Z-
score, calculated as (x−μ)/σ, where, for example, x is the raw number of annotations in
sample A, μ is the mean number of annotations in the distribution for sample B, and σ is the
standard deviation of B’s distribution. In essence, this results in two Z-scores, one
comparing A to B and one comparing B to A, and consequently the minimum |Z| was used.
According to the Central Limit Theorem, random sampling with replacement results in a
normal distribution, so Z-scores > 1.65 (P < 0.05) were considered enriched. In KEGG
pathway analysis, Bonferroni was used to correct for multiple hypotheses, where the P-value
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cutoff 0.05/n (n was the number of total third-level pathways identified in our phage
metagenomes) was converted to a Z-score.
Phage infection of microbiota
Microbiota were isolated from fecal samples of naïve mice as previously described31, except
PBS + 0.1% cysteine supernatants were plated on four separate LB agar plates. Colonies
were grown aerobically for 24 hours before plates were scraped with 2 ml LB, amassed, and
cultured at 37 °C and 300 RPM for two hours. This mixture was stored as 150 μl aliquots in
15% glycerol at −80 °C. For each experiment, an entire aliquot was used as the inoculum to
minimize growth biases. Phage were isolated as described above. Due to limited sample
availability, we harvested phage from mice that had been treated for five weeks for
ciprofloxacin experiments and phage from mice that had been treated for three weeks for
ampicillin experiments along with phage from control mice, respectively. Phage
preparations from drug-treated mice and control mice were diluted to the same volume, split
equivalently, and incubated with 0.25 ml microbiota (cultured to exponential phase in 0.2%
maltose) with 5 mM CaCl2 and 10 mM MgSO4. Phage-microbiota mixtures were allowed to
adsorb for one hour at 37 °C (no shaking). Phage-infected microbiota were then pelleted,
resuspended in fresh LB, and plated on LB agar plates with ciprofloxacin (1 μg/ml) or LB
agar plates with ampicillin (4 μg/ml). A 10 μl aliquot was serially diluted and plated onto
no-drug LB agar plates. Frequency was calculated as: # of colonies on drug plate divided by
# of colonies on no-drug plate. Additionally, the basal frequency of resistant isolates from
microbiota was measured as above in the absence of phage, and this frequency was
confirmed to be lower than that from microbiota infected with phage from either treated or
untreated mice.
Quantification of 16S rRNA
Quantitative PCR was used to measure levels of the 16S rRNA gene in our viral
preparations. We used the universal primers 8F and 338R9, and qPCR was performed using
the SYBR Green I Master kit and the LightCycler 480 (Roche) according to manufacturer’s
instructions.
Contig assembly and identification of phage-bacterial associations
Contigs were assembled using the Roche 454 GS De Novo Assembler with default
parameters, except for a minimum overlap of 100 bp and a minimum identity of 100% to
minimize erroneous alignments. Phage-bacterial associations were determined by computing
the combination of phage phylogenetic annotations and bacterial phylogenetic annotations
on a given contig, and non-redundant phage-bacterial associations were amassed for all
contigs. To evenly compare the number of phage-bacterial associations across samples, we
performed 50 assemblies using 60,000 randomly selected sequences with replacement from
each sample. The data presented in Fig. 4 are representative of these 50 assemblies such that
an association was illustrated if it was present in at least one assembly analysis. We
computed the mean number of phage-bacterial associations for a given sample (Fig. S8)
from the number of non-redundant associations found in each assembly trial. Significance
was determined by comparing sample values using the Mann-Whitney U-test. We computed
the mean bacteria-to-phage ratio for a given sample (Fig. S9) from the number of bacterial
species associated with a given phage for all phage using the union of associations from 50
assemblies shown in Fig. 4. Significance was determined by comparing sample values using
the Mann-Whitney U-test.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Antibiotic resistance is enriched in phage metagenomes following drug perturbation in
mice
a, b, Z-scores are shown for sequencing reads annotated as antibiotic resistance genes in
phage from ciprofloxacin-treated mice (red) and phage from ampicillin-treated mice
(yellow) in comparison to respective control mice. Dashed lines correspond to a Z-score of
1.65 (P = 0.05). Phage-encoded resistance genes were classified according to the drug class
to which they confer resistance (a) and by their mechanism of resistance (b). c, Frequency of
colonies resistant to ciprofloxacin (1 μg/ml) upon infection of microbiota with phage from
ciprofloxacin-treated mice or phage from control mice (left), and frequency of colonies
resistant to ampicillin (4 μg/ml) upon infection of microbiota with phage from ampicillin-
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treated mice or phage from control mice (right). P-values from Mann-Whitney U-test; n >
12. Mean ± s.e.m. *P < 0.05.
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Figure 2. Broad bacterial functions are enriched in phage metagenomes following drug
perturbation in mice
Network depicts KEGG pathways significantly enriched with antibiotic treatment compared
to controls. Treatments are represented by large nodes; enriched pathways are represented
by small nodes, grouped by their higher-level processes, and colored by the treatment
condition (red – ciprofloxacin; yellow – ampicillin; orange – common to both treatments). In
total, we identified 24 out of 188 pathways enriched with ciprofloxacin treatment (Z ≥ 3.46,
Bonferroni corrected) and 18 out of 178 pathways enriched with ampicillin treatment (Z ≥
3.43, Bonferroni corrected).
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Figure 3. Investigation of bacterial functions encoded in phage
a, Bacterial enzymes from sugar metabolism to glycolysis (left) with corresponding Z-scores
in phage from drug-treated mice in comparison to control mice (right). Dashed line
corresponds to a Z-score of 1.65 (P = 0.05). b, Class-level taxonomic distribution of all
sequences of bacterial origin identified in phage sequencing data (far left) and sequences
annotated with enriched functions following drug perturbation. “Other” constitutes taxa that
contributed less than 1% to all distributions.
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Figure 4. Phage-bacterial ecological network
Dash marks represent associations between virotypes and bacterial species identified from
phylogenetic analysis of reconstructed phage genomes. Phage-bacterial associations only in
control metagenomes (black), only in drug-treated metagenomes (red), and commonly
identified in control and drug-treated metagenomes (gray). Data are the union of
associations identified in 50 assemblies of randomly sampled reads from each treatment.
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